Physician profile
Joshua E Lee
NPI 1689031890
$6,022.84
in general payments reported to CMS, 2019-2025
21 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $688 · 2022: $1,088 · 2023: $917 · 2024: $2,280 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,596 · Travel and Lodging: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,596.28 |
| Travel and Lodging | $649.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,844.73 | 2021-2025 | Watchman Flx, Watchman, Watchman Access System |
| Abbott Laboratories | $673.76 | 2021-2025 | Aveir, Jot Dx, Gallant |
| Pfizer INC. | $348.83 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $304.99 | 2021-2024 | |
| Philips North America LLC | $297.27 | 2022-2025 | Mcot, (Ck4) Mcot |
| Medtronic, INC. | $221.83 | 2021-2025 | Selectsecure, Tyrx, Linq II |
| Atricure, INC. | $214.26 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.94 | 2021-2025 | Lifevest |
| Abiomed | $184.88 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $166.64 | 2021-2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.48 | 2022-2023 | Jardiance |
| Impulse Dynamics (USA) INC. | $116.71 | 2022-2023 | Optimizer |
| Amgen INC. | $82.58 | 2022-2023 | Repatha |
| Merck Sharp & Dohme LLC | $45.54 | 2024-2025 | Winrevair, Verquvo |
| Esperion Therapeutics, INC. | $44.30 | 2023-2024 | Nexletol |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $32.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.28 | 2025 | |
| Novo Nordisk INC | $21.76 | 2024 | |
| Janssen Pharmaceuticals, INC | $17.87 | 2023 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $15.95 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.